These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35447490)

  • 1. Degradation kinetics and characterization of major degradants of binimetinib employing liquid chromatography-high resolution mass spectrometry.
    Rajput N; Soni F; Sahu AK; Jadav T; Sharma S; Sengupta P
    J Pharm Biomed Anal; 2022 Jun; 215():114753. PubMed ID: 35447490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of stability-indicating assay method and liquid chromatography-quadrupole-time-of-flight mass spectrometry-based structural characterization of the forced degradation products of alpelisib.
    Ghanghav V; Chawathe A; Chauthe SK; Sharma N
    Biomed Chromatogr; 2024 Mar; 38(3):e5813. PubMed ID: 38148302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
    Kathar N; Rajput N; Jadav T; Sengupta P
    J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development.
    Bhangare D; Rajput N; Jadav T; Sahu AK; Sengupta P
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9417. PubMed ID: 36226771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the hydrolytic degradation behaviour of bictegravir by LC-PDA-Q/TOF-MS/MS NMR and in silico toxicity assessment.
    Dannarm SR; Harini D; Reddy GN; Ali N; Sonti R
    J Pharm Biomed Anal; 2024 Feb; 239():115909. PubMed ID: 38104374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of urapidil stress degradation products by LC-Q-TOF-MS and NMR: Toxicity prediction of degradation products.
    Velip L; Dhiman V; Kushwah BS; Golla VM; Gananadhamu S
    J Pharm Biomed Anal; 2022 Mar; 211():114612. PubMed ID: 35101803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization and in silico toxicity prediction of degradation impurities of roxadustat.
    Mahajan R; Kumar S; Parupalli R; Khemchandani R; Kanchupalli V; Nanduri S; Samanthula G; Asthana A
    J Pharm Biomed Anal; 2023 Sep; 234():115517. PubMed ID: 37320975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
    Shekhar S; Bali A
    Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
    Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
    Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delineation of prototypical degradation mechanism, characterization of unknown degradation impurities by liquid chromatography-quadrupole-time-of-flight-tandem mass spectrometry and stability-indicating analytical method of selumetinib.
    Mishra S; Rajput N; Jadav T; Panday NK; Sahu AK; Sengupta P
    Biomed Chromatogr; 2024 Jan; 38(1):e5761. PubMed ID: 37920143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
    Jain M; Khan S
    J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
    Matta A; Sundararajan R
    Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forced degradation study of racecadotril: Effect of co-solvent, characterization of degradation products by UHPLC-Q-TOF-MS/MS, NMR and cytotoxicity assay.
    Chiguru V; Lingesh A; R S; N S
    J Pharm Biomed Anal; 2016 Sep; 128():9-17. PubMed ID: 27209450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hesperidin: Enrichment, forced degradation, and structural elucidation of potential degradation products using spectral techniques.
    Bisen AC; Rawat P; Sharma G; Sanap SN; Agrawal S; Kumar S; Kumar A; Choudhury AD; Kamboj S; Narender T; Shukla SK; Kanojiya S; Bhatta RS
    Rapid Commun Mass Spectrom; 2023 Oct; 37(20):e9615. PubMed ID: 37706431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.